DAIKEN MEDICAL CO.,LTD.
大研医器株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 7775
FY2025 (Mar 2026) · J-GAAP · parent-only (non-consolidated) Source: filing S100YCII
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 38.4% |
|---|---|
| Operating margin | 12.4% |
| Net margin | 9.0% |
| Return on equity | 12.1%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 8.2% |
| Revenue growth (YoY) | 3.4% |
| EPS (basic) | ¥32.12 |
| EPS growth (YoY) | -15.9% |
| Current ratio | 2.58x |
| Equity ratio | 68.2% |
| Book value / share | ¥269.65 |
| Free cash flow | ¥240M |